Back to search

Article

Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study

2022-11-18

Abstract excerpt

<h4>Background</h4> Kidney disease is a key risk factor for COVID-19-related mortality and suboptimal vaccine response. Optimising vaccination strategies is essential to reduce the disease burden in this vulnerable population. <h4>Methods</h4> With the approval of NHS England, we performed a retrospective cohort study to estimate the comparative effectiveness of schedules involving AZD1222 (AZ; ChAdOx1-S) and BNT1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1b0d3c2-56b6-5948-a631-1cd72a696f41
DOI
10.1101/2022.11.16.22282396
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort studyDOI 10.1101/2022.11.16.22282396
Select a neighboring publication to make it the new centre.